Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 137.98M P/E - EPS this Y 69.60% Ern Qtrly Grth -
Income -41.85M Forward P/E -5.20 EPS next Y 20.60% 50D Avg Chg 10.00%
Sales 2.41M PEG - EPS past 5Y - 200D Avg Chg 24.00%
Dividend N/A Price/Book 7.54 EPS next 5Y - 52W High Chg -28.00%
Recommedations 1.00 Quick Ratio 0.50 Shares Outstanding 63.78M 52W Low Chg 177.00%
Insider Own 3.62% ROA -88.32% Shares Float 58.02M Beta 1.91
Inst Own 6.77% ROE -651.40% Shares Shorted/Prior 673.72K/894.62K Price 2.91
Gross Margin 6.31% Profit Margin - Avg. Volume 674,075 Target Price 4.00
Oper. Margin -1,175.60% Earnings Date - Volume 38,545 Change 1.39%
About Renalytix plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.

Renalytix plc News
04/08/24 Renalytix Announces Financing with Expected Size of up to $4 Million
03/25/24 3 Ridiculously Enticing Stocks to Buy for Under a Buck
03/14/24 KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
02/15/24 Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
02/09/24 Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
01/10/24 New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
11/14/23 Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
11/07/23 Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
10/16/23 What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
10/06/23 US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
10/05/23 Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10/03/23 Renalytix Plc (NASDAQ:RNLX) Q4 2023 Earnings Call Transcript
09/25/23 Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28
09/07/23 Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
08/03/23 Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
07/21/23 Renalytix Announces Middle East Distribution Agreement with Vector Pharma
07/07/23 Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
07/03/23 Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
06/29/23 FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
06/15/23 KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences
RNLX Chatroom

User Image theRooster007 Posted - 2 days ago

$RNLX my question is what are we planning to do with .5million... Last earnings said runway to end of April, with cashburn much higher than .5 million...possibly paying themselves before deal? News this month or may imo

User Image theRooster007 Posted - 2 days ago

$RNLX weird

User Image Denzerini Posted - 2 days ago

$RNLX Form 8-K has been filed. Previous President officially replaced. CBO promoted as the new Prez.

User Image celtics34 Posted - 3 days ago

$RNLX also looks like they are now offering UAGR testing... i wonder what they are charging and what the ramp on this is, i know its a general test, but compliments kidneyintelx

User Image celtics34 Posted - 3 days ago

$RNLX found this on the kidneyintelx website... they haven't really publicly announced these plans, nice to see they have some programs in play to further expand kidneyintelx and partner on the drug side

User Image theRooster007 Posted - 3 days ago

$RNLX so db is officially down on investment lol

User Image theRooster007 Posted - 4 days ago

$RNLX on the clock...

User Image theRooster007 Posted - 4 days ago

$RNLX

User Image Woodman7 Posted - 1 week ago

$RNLX

User Image theRooster007 Posted - 1 week ago

$RNLX Thomas Mclain Stepping Down. Perhaps we are getting close to decisions...

User Image DonCorleone77 Posted - 1 week ago

$RNLX Renalytix files to sell 19.99M ordinary shares for holders

User Image theRooster007 Posted - 1 week ago

$RNLX

User Image Woodman7 Posted - 1 week ago

$RNLX - Any chance we get some info tomorrow morning?? Merger Monday!

User Image buyandsold Posted - 2 weeks ago

$RNLX what does this vote mean Authorizing the Board of Directors to allot ordinary shares of £0.0025 each in the capital of the Company up to an aggregate nominal amount of £67,039.6025 (26,815,841 ordinary shares) (the "Second Tranche Placing Shares")

User Image theRooster007 Posted - 2 weeks ago

$RNLX wondering how we look from a compliance standpoint. We've been under 1$ for some time now

User Image Woodman7 Posted - 2 weeks ago

@Hawker41 @theRooster007 - yes it is. But it also puts a solid floor under it in my opinion. $RNLX

User Image Woodman7 Posted - 2 weeks ago

@theRooster007 - which means $RNLX is a pretty compelling buy at current prices

User Image Woodman7 Posted - 2 weeks ago

$RNLX - well we know for sure that DB Healthcare did a bunch of due diligence and decided to put some money to work here. Not a lot for them, but still $4m is $4m. And they know a lot more about what’s going on than I do…

User Image Shiftyshorif Posted - 2 weeks ago

$RNLX got a email about voting but what shall I vote for, don't really understand it.

User Image whizmann Posted - 2 weeks ago

$RNLX sounds like an offering without the word offering. Whatever happened to the buyout?

User Image TrkDvr Posted - 2 weeks ago

$RNLX I wouldn't have thought a company would be raising capital while negotiating a sale. Doesn't this raise the price or dilute the shareholder value? It appears that the offer to buy isn't very attractive.

User Image theRooster007 Posted - 2 weeks ago

$RNLX so did they just tell Capital Partners Healthcare, L.P. we are selling our company and we need financing at $0.75 per NASDAQ ADS?? Lol

User Image firewire11 Posted - 2 weeks ago

$RNLX just sell the damn thing

User Image RealErnFranklin Posted - 2 weeks ago

$RNLX pump it

User Image Stock_Titan Posted - 2 weeks ago

$RNLX Renalytix Announces Financing with Expected Size of up to $4 Million https://www.stocktitan.net/news/RNLX/renalytix-announces-financing-with-expected-size-of-up-to-4-9ia44cj2k9k3.html

User Image theRooster007 Posted - 2 weeks ago

$RNLX update

User Image Themoose1 Posted - 2 weeks ago

$RNLX https://investors.renalytix.com/news-releases/news-release-details/financing-expected-size-4-million

User Image Americanbulls Posted - 3 weeks ago

$RNLX the bull pattern is not confirmed. A new bull pattern is detected. www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=RNLX

User Image theRooster007 Posted - 3 weeks ago

$RNLX looks like we changed addresses haha. Heck of a PR

User Image celtics34 Posted - 3 weeks ago

$RNLX is primarily held by insiders and institutions, rather than being heavily owned by retail investors, that being said, i do not see it dropping long term, especially below the 1st placement completed on March 12th.

Analyst Ratings
HC Wainwright & Co. Buy Jun 30, 23
HC Wainwright & Co. Buy Jun 12, 23
HC Wainwright & Co. Buy Jun 5, 23
BTIG Buy Apr 3, 23
HC Wainwright & Co. Buy Apr 3, 23
HC Wainwright & Co. Buy Dec 2, 22
HC Wainwright & Co. Buy Nov 1, 22
BTIG Buy Jul 1, 22
Stifel Buy Jul 1, 22